N-Nonyldeoxynojirimycin
N-Nonyldeoxynojirimycin (NN-DNJ) is a deoxynojirimycin derivative with a hydrophobic long chain. N-Nonyldeoxynojirimycin is an orally active inhibitor of acid α-glucosidase (IC50: 0.42 μM) and α-1,6-glucosidase (IC50: 8.4 μM) . N-Nonyldeoxynojirimycin has activities of inhibiting glycogen breakdown, anti-virus and anti-tumor. N-Nonyldeoxynojirimycin also has insecticidal effects, with an LD50 of 5 mM for adults of Bemisia tabaci[1][2][3][4].
Product Specifications
CAS Number
81117-35-3
Product Name Alternative
NN-DNJ; Nonyl-DNJ
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Flavivirus; Glycosidase; Parasite
Type
Peptides
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer; Infection; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/n-nonyldeoxynojirimycin.html
Purity
99.0
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
OC[C@H]1N(C[C@H](O)[C@@H](O)[C@@H]1O)CCCCCCCCC
Molecular Formula
C15H31NO4
Molecular Weight
289.41
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD44 Standard (DF1485), CF594 conjugate, 0.1mg/mL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF594 conjugate, 0.1mg/mL
Pmel17 / gp100 / SILV (NKI-beteb), CF740 conjugate, 0.1mg/mL
